Caricamento...
LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression
ErbB2/HER2/Neu-overexpressing breast cancers are characterized by poor survival due to high proliferation and metastasis rates and identifying downstream targets of ErbB2 should facilitate developing novel therapies for this disease. Gene expression profiling revealed the transcriptional regulator L...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2762490/ https://ncbi.nlm.nih.gov/pubmed/19648968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2009.221 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|